Last updated: April 23, 2026
Who Supplies Naloxone Hydrochloride and Pentazocine Hydrochloride?
What suppliers control the supply chain for Naloxone Hydrochloride?
Naloxone hydrochloride (often formulated as injectable solutions) is supplied by manufacturers that hold commercial production capacity for generic injectables and, in some cases, branded product lines. The most frequently cited manufacturers and commercial sources for naloxone hydrochloride injections include:
| Supplier / Manufacturer |
What they supply |
Common dosage form(s) |
Notes |
| Sagent Pharmaceuticals |
Naloxone hydrochloride |
Injectable |
Major generic injectable supplier |
| Mylan (now part of Viatris) |
Naloxone hydrochloride |
Injectable |
Commercial-scale generic injectable production |
| West-Ward / Hikma (historical branded generic lines under distribution networks) |
Naloxone hydrochloride |
Injectable |
Often appears across distributor and label traces |
| Teva |
Naloxone hydrochloride |
Injectable |
Large generic sterile injectables footprint |
Which suppliers control the supply chain for Pentazocine Hydrochloride?
Pentazocine hydrochloride (a Schedule IV opioid analgesic in many markets) is supplied by manufacturers producing controlled-substance analgesic injectables and related dosage forms. Commonly identified suppliers include:
| Supplier / Manufacturer |
What they supply |
Common dosage form(s) |
Notes |
| Pfizer |
Pentazocine hydrochloride |
Injectable (historically common) |
Long-established opioid analgesic manufacturer |
| Mylan |
Pentazocine hydrochloride |
Injectable |
Generic controlled-substance supply |
| Sandoz |
Pentazocine hydrochloride |
Injectable |
Sterile manufacturing footprint for injectables |
| Teva |
Pentazocine hydrochloride |
Injectable |
Generic analgesic production capacity |
What does “supplier” mean in this context?
In pharmaceutical sourcing, “supplier” typically refers to one of three parties:
- API or finished-dose manufacturer (the actual producer of naloxone/pentazocine hydrochloride drug substance or sterile product).
- Market authorization holder / labeler (brand owner or generic labeler that lists the product for sale).
- Wholesaler / distributor network (the go-to-market channel, not the producer).
The lists above reflect manufacturing suppliers that are repeatedly present across commercial injectable supply networks for these hydrochloride salts.
How do you shortlist suppliers for procurement or qualification?
Procurement qualification for sterile injectables generally prioritizes:
- Sterile manufacturing pedigree (aseptic fill-finish and quality system maturity)
- Regulatory inspection outcomes for sterile product lines
- Batch release capability (controlled substance handling for pentazocine)
- Lead time stability (capacity and scale for injectable production)
For naloxone hydrochloride, the supplier pool is typically broader because it is widely used for opioid overdose reversal across multiple healthcare settings. For pentazocine hydrochloride, the supplier pool tends to be narrower due to tighter controlled-substance supply chain requirements.
What are the practical supplier-selection differences between the two drugs?
Naloxone hydrochloride
- Broad generic injectable availability
- Lower controlled-substance restrictions than most opioid analgesics (though still regulated as an opioid antagonist)
- Often supported by multiple large generic sterile players
Pentazocine hydrochloride
- Controlled-substance handling requirements
- More limited supplier universe in many jurisdictions
- Requires procurement workflows that account for regulatory custody and distribution
Key Takeaways
- Naloxone hydrochloride injection supply is anchored by large generic injectable manufacturers and established sterile producers (examples include Sagent, Mylan/Viatris, Teva, and legacy sterile networks such as West-Ward/Hikma).
- Pentazocine hydrochloride supply relies more heavily on a smaller set of manufacturers with controlled-substance capability (examples include Pfizer, Mylan, Sandoz, Teva).
- Supplier qualification for both drugs hinges on sterile manufacturing capability, regulatory track record, and reliable batch release; pentazocine adds controlled-substance custody constraints.
FAQs
1) Are naloxone hydrochloride and pentazocine hydrochloride typically sourced as API or finished drug product?
Most healthcare procurement and hospital purchasing favors finished-dose injectable products from approved labelers, with API sourcing handled through the manufacturer supply chain.
2) Do manufacturers commonly change the labeler even when the product stays the same?
Yes. Generic injectables can be relabeled due to market authorizations, distribution contracts, or contract manufacturing arrangements.
3) What supplier attribute matters most for sterile naloxone injectables?
Aseptic fill-finish capacity and batch release reliability under a validated sterile manufacturing system.
4) What supplier attribute matters most for pentazocine controlled-substance injectables?
Controlled-substance compliance and custody capability across manufacturing, storage, and distribution.
5) Can one supplier handle both naloxone and pentazocine hydrochloride lines?
Yes, where a supplier has both broad sterile injectable production and controlled-substance manufacturing and distribution capability.
References
- FDA Drug Shortages. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages
- Drugs@FDA. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/ob/
- DEA Diversion Control Division. U.S. Drug Enforcement Administration. https://www.deadiversion.usdoj.gov/
